Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study

HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis

NCT01784939 ·Status: COMPLETED

Genomic Screening for Hereditary Erythrocytosis and Related Diseases

NCT03263364 ·Status: UNKNOWN

Statistical Basis for Hemochromatosis Screening

NCT00005559 ·Status: COMPLETED

A Long-term Follow-up Study in Participants Who Received CS-101

NCT06685536 ·Status: ENROLLING_BY_INVITATION

PTG-300 in Subjects With Hereditary Hemochromatosis

NCT04202965 ·Status: COMPLETED ·Phase: PHASE2

Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19

NCT04746066 ·Status: RECRUITING

Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis

NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals

NCT05370677 ·Status: UNKNOWN

Registry of Congenital Dyserythropoietic Anemia

NCT03983629 ·Status: UNKNOWN

National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell

NCT04778657 ·Status: RECRUITING

Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia

NCT00069862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy

NCT01588665 ·Status: COMPLETED

Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia

NCT01496963 ·Status: COMPLETED

Genetic Variants Affecting the Clinical Severity of Beta Thalassemia

NCT04918056 ·Status: UNKNOWN

Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China

NCT05125341 ·Status: COMPLETED

Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients

NCT04667325 ·Status: COMPLETED

Pharmacogenetic Study in Patients Received Iron Chelating Agent

NCT01623895 ·Status: COMPLETED

Immunopathology of Autoimmune Hemolytic Anemia

NCT02158195 ·Status: COMPLETED

Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer

NCT01019096 ·Status: COMPLETED

Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes

NCT02855957 ·Status: COMPLETED ·Phase: NA

The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia

NCT05214105 ·Status: RECRUITING

Study of the Pathogenesis of Porphyria Cutanea Tarda

NCT00005103 ·Status: COMPLETED

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

NCT01394029 ·Status: COMPLETED

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

NCT04779593 ·Status: RECRUITING ·Phase: NA

A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

NCT06717932 ·Status: ENROLLING_BY_INVITATION